Pfizer, Inc. (NYSE:PFE)

Friday, August 28, 2009 | Web News
“Our results this quarter demonstrate our ability to continue to deliver solid operational performance despite a challenging and dynamic economic and operating environment. On a constant...
Sunday, July 19, 2009 | Web News
Per an April 28, 2009 press release, Pfizer’s financial full-year 2009, guidance is unchanged from the guidance provided on January 26, 2009,...
Monday, January 26, 2009 | Web News
Guidance Report: > Source: Business Wire (January 26, 2009)...
See All Research...
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines, as well as consumer healthcare products. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines, as well as products for consumer healthcare. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

Last updated February 2, 2018